Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Titel:
Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Auteur:
Kim, Dong Hyun Lim, Seung Taek Kim, Hye Ryun Kang, Eun Joo Ahn, Hee Kyung Lee, Yun-Gyoo Sun, Der Sheng Kwon, Jung Hye Lee, Sang-Cheol Lee, Hyun Woo Kim, Min Kyoung Keam, Bhumsuk Park, Keon-Uk Shin, Seong-Hoon Yun, Hwan Jung